Led by $255m venture financing of InSilico Medicine, North America’s medical devices industry saw a drop of 5.08% in artificial intelligence deal activity during Q2 2021, when compared to the last four-quarter average, according to GlobalData’s deals database.
A total of 28 artificial intelligence deals worth $1.2bn were announced for the region during Q2 2021, against the last four-quarter average of 29.50 deals.
Of all the deal types, venture financing saw most activity in Q2 2021 with 21 deals, representing a 75% share for the region.
In second place was M&A with four deals, followed by private equity deals with three transactions, respectively capturing a 14.3% and 10.7% share of the overall artificial intelligence deal activity for the quarter.
